Mylan, Fujifilm win EU okay for copy of AbbVie's Humira
Mylan and Fujifilm Kyowa Kirin Biologics said on Thursday they had won European approval to market a cheaper copy of AbbVie's $18-billion-a-year biologic drug Humira, the world's best-selling prescription medicine.
from Reuters: Health News https://reut.rs/2OGE3nF
http://bit.ly/2zwRqiM